Systemic antifungal therapy for proven or suspected invasive candidiasis: the AmarCAND 2 study.
about
Diagnosis and management of invasive candidiasis in the ICU: an updated approach to an old enemySpecific Human and Candida Cellular Interactions Lead to Controlled or Persistent Infection Outcomes during Granuloma-Like Formation.The risk and clinical outcome of candidemia depending on underlying malignancy.Plant extracts: initial screening, identification of bioactive compounds and effect against Candida albicans biofilms.The impact of real life treatment strategies for Candida peritonitis-A retrospective analysis.The current treatment landscape: candidiasis.Clinical characteristics and predictors of mortality in cirrhotic patients with candidemia and intra-abdominal candidiasis: a multicenter study.Changes in the distribution of colonising and infecting Candida spp. isolates, antifungal drug consumption and susceptibility in a French intensive care unit: A 10-year study.Biomarker-based strategy for early discontinuation of empirical antifungal treatment in critically ill patients: a randomized controlled trial.What has changed in the treatment of invasive candidiasis? A look at the past 10 years and ahead.Biomarker-guided antifungal therapy in patients with suspected invasive candidiasis: Ready for prime time?De-escalation of antifungal treatment in critically ill patients with suspected invasive Candida infection: incidence, associated factors, and safety.Echinocandins for management of invasive candidiasis in patients with liver disease and liver transplantation.
P2860
Q26745677-4BEE18F9-CDE0-45DC-91FE-BC3736A8038DQ30833475-63E6B7A1-2432-4706-899F-EE3C726FEAEAQ37742252-423BE8F0-C60F-462E-9558-486E825609FAQ38786620-C8CEA5E9-A379-4695-A78B-F4587D63BB7FQ38859366-AF021222-8890-4600-8031-159825680278Q39018200-56E9824D-78E0-4EB6-BA4E-57AAD9CF14D5Q40066371-C1B65187-B043-4E79-955D-38E9C0A385EFQ40101767-0988C5BF-6008-45F9-BCD4-1FB9929A1DEDQ47678193-E89CC7A4-DBA2-4535-AB58-D2F3C73A47B1Q47749829-EDBA2806-758C-44B2-8202-51D673190124Q50101377-CC98C168-7F91-4A84-A5DF-5BC8BBFB38BBQ52575674-BF933109-DC96-43C7-96C8-F82A5ACEE940Q54957028-499640AD-7BA7-487F-8507-22AF2FB2B042
P2860
Systemic antifungal therapy for proven or suspected invasive candidiasis: the AmarCAND 2 study.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Systemic antifungal therapy fo ...... idiasis: the AmarCAND 2 study.
@ast
Systemic antifungal therapy fo ...... idiasis: the AmarCAND 2 study.
@en
type
label
Systemic antifungal therapy fo ...... idiasis: the AmarCAND 2 study.
@ast
Systemic antifungal therapy fo ...... idiasis: the AmarCAND 2 study.
@en
prefLabel
Systemic antifungal therapy fo ...... idiasis: the AmarCAND 2 study.
@ast
Systemic antifungal therapy fo ...... idiasis: the AmarCAND 2 study.
@en
P2093
P2860
P50
P1476
Systemic antifungal therapy fo ...... idiasis: the AmarCAND 2 study.
@en
P2093
AmarCAND2 study group
Caroline Bensoussan
Elie Azoulay
Hervé Dupont
Jean-Michel Constantin
Jean-Pierre Gangneux
Olivier Leroy
Philippe Montravers
Pierre-François Perrigault
Sébastien Bailly
P2860
P2888
P356
10.1186/S13613-015-0103-7
P577
2016-01-08T00:00:00Z
P5875
P6179
1015101526